In agreement with these findings, a Villin-CreERT2-driven Usp22 deletion alone resulted in a slightly increased colitis-related disease activity index (DAI; Figure 1A,B) which was calculated based on weight loss, intestinal bleeding intensity and stool consistency (Figure 1C–E). The gene discussed is USP22; the disease is colitis.